Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607784 · ClinicalTrials.gov registry record
Education Program to Reduce Risky Behavior in Adolescents Ph I
A clinical trial, sponsored by Klein Buendel.
- Completed
- Registry status
- 24
- Enrollment target
NCT05607784: Completed study, sponsored by Klein Buendel.
NCT05607784 is a clinical trial that has completed, run by Klein Buendel. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05607784 has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This phase will complete the TRAC adaptation to a web app. The pilot study (R21 HD089979) effectively translated the ER content of TRAC and the same procedures will be used to translate the remaining content.
Primary Outcome
Advisory Focus Groups: Research summaries will also be generated to communicate with participating communities. Using these recommended D4D processes, the research will be better positioned for dissemination (and commercialization)
Interventions
- BEHAVIORAL Formative Research- Content Translation
- BEHAVIORAL Formative Research- Content Feedback and Acceptability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-11-28 |
| Est. Completion | 2023-06-30 |
What the finished NCT05607784 record still lists
NCT05607784 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Formative Research- Content Translation is the first listed.
NCT05607784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05607784 about?
NCT05607784 is a clinical study titled "Education Program to Reduce Risky Behavior in Adolescents Ph I". This phase will complete the TRAC adaptation to a web app. The pilot study (R21 HD089979) effectively translated the ER content of TRAC and the same procedures will be used to translate the remaining content.
What is the current status of trial NCT05607784?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2022-11-28. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05607784?
The interventions under investigation include: Formative Research- Content Translation (BEHAVIORAL), Formative Research- Content Feedback and Acceptability (BEHAVIORAL).
Who is sponsoring clinical trial NCT05607784?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI